Bin Liu

Company: HB Therapeutics, Inc.

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Interrogating the Properties & Characteristics of Molecular Glues to Develop the Most Effective Degraders 12:00 pm

As an industry, how should we define molecular glues going forward to establish great drug discovery and development opportunities that address unmet patient needs? What are the ideal properties of molecular glues that small molecules can be optimized towards? Where does a molecular glue end and a PROTAC begin? New CompanyRead more

day: Conference Day Two

Exploring Chemical Space of Molecular Glues to Identify Suitable Ligands for Novel E3 Ligases 1:15 pm

Discovering novel small molecule glues for targeted protein degradation of SUMO1 Utilizing the E3 ligase complex structure for structure-based glue degrader design SUMO1 degradation MOA and SAR highlight for potency and properties New Data New CompanyRead more

day: Conference Day One